← All trials
NCT03343600
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 9, 2017
- Primary completion
- Sep 30, 2019
- Completion date
- Mar 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 92
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Taiwan UniversityLead sponsor
- National Taiwan UniversityOverall official - principal investigator
- Government of TaiwanCollaborator
- Far Eastern Memorial HospitalCollaborator
- National Cheng Kung UniversityCollaborator
- Hualien Tzu Chi General HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.